.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

AHS 2021
Future Leaders in Neurology
Spotlight: Migraine
Spotlight: MS

Clinical FocusSee All >

Dementia/Alzheimer
Epilepsy
Headache/Migraine
Movement Disorders
Multiple Sclerosis
Neuromuscular
Sleep Medicine
Stroke

Video Series

Cure Connections
Insights
News Network
Peer Exchange

Advertise
Contact Us
Editorial
Do Not Sell My Information
Terms and Conditions
Privacy
Advisory Board

Expert Perspectives: Advances in the Management of Acute Migraine

EP. 1: Acute Migraine Management: Overview and Unmet Needs

January 18th 2021

EP. 2: Goals of and Recommended Approach for Acute Treatment

January 18th 2021

EP. 3: Acute Migraine Treatment: Pain Freedom and Guidelines

January 18th 2021

EP. 4: Therapy Assessment: Pain Relief & Onset Monitorization

January 18th 2021

EP. 5: The Importance of Patient Communication

January 18th 2021

EP. 6: Recent Approvals for Acute Migraine

January 18th 2021

EP. 7: The Significance of 5-HT1F Agonist Approval

January 18th 2021

EP. 8: 5-HT1F Agonist Toxicity Profile and Role in Paradigm

January 18th 2021

EP. 9: CGRP Receptor Agonists: Safety and Efficacy

January 18th 2021

EP. 10: The Role of Developing Agents in Acute Migraine Paradigm

January 18th 2021